Synsorb Pk vs placebo
Incidence of HUS · patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether synsorb Pk changes incidence of HUS compared with placebo (very low certainty).
1 finding from 1 review
- Interventions for preventing diarrhoea‐associated haemolytic uraemic syndrome 2021 · Cochrane Headline outcomes onlyRR 0.93 [0.39, 2.22]1 study · 353 participantsVery low